VL-3 Training Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 343 participants.

Also called NCT05356754

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 343 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05356754
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05356754. Allocation not applicable; no masking; primary purpose other. Start 2020-07-13 (actual); primary completion 2021-11-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VL-3 Training Study
Condition
Hypertension
Condition
Blood Pressure
Intervention (Device)
The Vital Labs Digital Blood Pressure Monitor
Lead sponsor
Riva Health (class: industry)
Collaborator
Diablo Clinical Research (class: not stated)
Collaborator
University of Colorado, Denver (class: other)

Record details

Record id
cardio:ct-nct05356754
Content hash
753b7c35c7e4aae72d2a3c006669b5bfdab8769c074999066b0e94b2062ad58c